Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing ...

The London Biotechnology Show returns for its highly anticipated second edition, building on the remarkable success of its ...

LUND, SE / ACCESS Newswire / May 20, 2025 / Alligator Bioscience (Nasdaq Stockholm:ATORX), a clinical stage biotechnology ...

Phase 3 clinical trial of BNC-210 in social anxiety disorder on track for topline readout in Q3 2025α7 nicotinic ...

The sale was for $256 million and is expected to be complete by the third quarter of this year, according to a Regeneron news ...

Bankrupt DNA testing company 23andMe was purchased Monday by biotechnology company Regeneron for $256 million. Both companies ...

By Nana Yaw Reuben Jr.The Open Forum on Agricultural Biotechnology in Africa a non-governmental organization fostering ...

The U.S. Food and Drug Administration (FDA) is currently conducting an on-site inspection of Samsung Biologics Co.'s ...

Philikos announces initiation of clinical Phase 1/2 study with T-Guard® in patients with systemic sclerosisNIJMEGEN, the Netherlands, May 20, 2025 (GLOBE NEWSWIRE) -- Philikos B.V., a Dutch ...

"Stacy is joining Upstream Bio at a pivotal time in our growth as we prepare to initiate a third clinical program for ...